Renaissance Technologies - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is and the CUSIP is 21234W400. A total of 1 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$43,00010,2880.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q3 2019
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders